Literature DB >> 20003967

A new metal stent with a controlled-release system for palliation of malignant dysphagia: a prospective, multicenter study.

Petra G A van Boeckel1, Alessandro Repici, Frank P Vleggaar, Biagio Solito, Giacomo Rando, Claudio Cortelezzi, Mauro Rossi, Nico Pagano, Alberto Malesci, Peter D Siersema.   

Abstract

BACKGROUND: Self-expanding metal stents are frequently used for the palliation of malignant dysphagia. Recently, a new stent design, the Evolution stent (Cook Medical, Limerick, Ireland), was developed. The stent has an internal and external silicone coating to resist tissue ingrowth and uncoated dual flanges on both ends to prevent migration. Its controlled-release system may allow full control and precise positioning of the stent.
OBJECTIVE: To determine the safety and clinical effectiveness of the Evolution stent for the palliation of dysphagia in patients with malignant strictures located in the esophagus (n = 33 [75%]) or gastric cardia (n = 11 [25%]).
METHODS: All patients who underwent placement of an esophageal Evolution stent from February to December 2008 received follow-up telephone calls 14 days after treatment and thereafter monthly until death. Data on technical and clinical outcome, complications, and recurrent dysphagia were collected.
RESULTS: A total of 44 patients (32 [73%] men, median age 74 years [range 48-91 years]) were treated with the Evolution stent. The median tumor length was 6 cm (range 1-11 cm). Stent placement was technically successful in 41 patients. Dysphagia improved from a median of 3 (ability to swallow liquids only) to 1 (ability to eat some solid foods) 4 weeks after stent placement. Major complications occurred in 4 (9%) patients, ie, pneumonia (3 patients) and hemorrhage (1 patient). Two (5%) patients died of pneumonia. Minor complications included gastroesophageal reflux and mild retrosternal pain in 11 (25%) and 4 (9%) patients, respectively. Recurrent dysphagia developed in 11 (25%) patients as a result of tissue ingrowth or overgrowth (6 patients; 14%), food impaction (3 patients; 7%), or stent migration (2 patients; 5%).
CONCLUSIONS: The Evolution stent is safe and effective for the palliation of dysphagia from esophageal and gastric cardia cancer. Randomized trials are needed to compare this device with other stent designs. 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20003967     DOI: 10.1016/j.gie.2009.09.046

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  8 in total

Review 1.  Role of stenting in gastrointestinal benign and malignant diseases.

Authors:  Benedetto Mangiavillano; Nico Pagano; Monica Arena; Stefania Miraglia; Pierluigi Consolo; Giuseppe Iabichino; Clara Virgilio; Carmelo Luigiano
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

2.  Endoscopic management of esophageal strictures.

Authors:  Vanessa M Shami
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-06

3.  History of the Use of Esophageal Stent in Management of Dysphagia and Its Improvement Over the Years.

Authors:  Kulwinder S Dua
Journal:  Dysphagia       Date:  2017-01-18       Impact factor: 3.438

4.  Gastrointestinal stent update.

Authors:  Sung-Gwon Kang
Journal:  Gut Liver       Date:  2010-09-10       Impact factor: 4.519

Review 5.  Esophageal stents in malignant and benign disorders.

Authors:  P Didden; M C W Spaander; M J Bruno; E J Kuipers
Journal:  Curr Gastroenterol Rep       Date:  2013-04

Review 6.  Interventions for dysphagia in oesophageal cancer.

Authors:  Yingxue Dai; Chaoying Li; Yao Xie; Xudong Liu; Jianxin Zhang; Jing Zhou; Xiongfei Pan; Shujuan Yang
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

7.  Comparison between gastrostomy feeding and self-expandable metal stent insertion for patients with esophageal cancer and dysphagia.

Authors:  Yang Won Min; Eun Young Jang; Ji Hey Jung; Hyuk Lee; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

8.  Early pain detection and management after esophageal metal stent placement in incurable cancer patients: A prospective observational cohort study.

Authors:  Agnes N Reijm; Paul Didden; Marco J Bruno; Manon C W Spaander
Journal:  Endosc Int Open       Date:  2016-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.